Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
(Adnkronos) – SAN DIEGO, April 19, 2023 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States
